- Home
- WD vs VCYT Comparison
WD vs VCYT Comparison
Compare WD & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WD
- VCYT
- Stock Information
- Founded
- WD 1937
- VCYT 2006
- Country
- WD United States
- VCYT United States
- Employees
- WD N/A
- VCYT N/A
- Industry
- WD Finance: Consumer Services
- VCYT Medical Specialities
- Sector
- WD Finance
- VCYT Health Care
- Exchange
- WD Nasdaq
- VCYT Nasdaq
- Market Cap
- WD 2.9B
- VCYT 2.6B
- IPO Year
- WD 2010
- VCYT 2013
- Fundamental
- Price
- WD $80.49
- VCYT $34.84
- Analyst Decision
- WD Buy
- VCYT Buy
- Analyst Count
- WD 1
- VCYT 9
- Target Price
- WD $95.00
- VCYT $39.89
- AVG Volume (30 Days)
- WD 232.4K
- VCYT 895.7K
- Earning Date
- WD 11-06-2025
- VCYT 11-05-2025
- Dividend Yield
- WD 3.30%
- VCYT N/A
- EPS Growth
- WD 25.06
- VCYT N/A
- EPS
- WD 3.24
- VCYT 0.34
- Revenue
- WD $1,111,017,000.00
- VCYT $479,129,000.00
- Revenue This Year
- WD $18.16
- VCYT $14.48
- Revenue Next Year
- WD $5.63
- VCYT $9.79
- P/E Ratio
- WD $25.08
- VCYT $102.86
- Revenue Growth
- WD 15.06
- VCYT 19.91
- 52 Week Low
- WD $64.48
- VCYT $22.61
- 52 Week High
- WD $118.19
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- WD 40.95
- VCYT 59.94
- Support Level
- WD $81.73
- VCYT $31.81
- Resistance Level
- WD $86.38
- VCYT $36.85
- Average True Range (ATR)
- WD 2.13
- VCYT 1.40
- MACD
- WD -0.63
- VCYT 0.06
- Stochastic Oscillator
- WD 2.24
- VCYT 60.91
About WD Walker & Dunlop Inc
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.